Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-20-068066
Filing Date
2020-06-01
Accepted
2020-06-01 09:46:58
Documents
1
Effectiveness Date
2020-06-01

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm2021472d1_defa14a.htm DEFA14A 20055
  Complete submission text file 0001104659-20-068066.txt   21132
Mailing Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312
Business Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312 610-727-3913
Annovis Bio, Inc. (Filer) CIK: 0001477845 (see all company filings)

EIN.: 262540421 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39202 | Film No.: 20931397
SIC: 2834 Pharmaceutical Preparations